PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) Announces Q1 Results for Clarmin Explorations
Cybin (NEO: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, on Tuesday announced the unaudited financial results of Clarmin Explorations Inc. (now Cybin Inc.) for the three month period ended Oct. 31, 2020. According to the update, a copy of the consolidated financial statements prepared in accordance with International Financial Reporting Standards, as well as the corresponding management’s discussion and analysis for the three months ended Oct. 31, 2020, can be found under Cybin’s profile at www.SEDAR.com. To view the full press release, visit https://ibn.fm/br5Uw About Cybin Inc. Cybin is a life sciences company advancing psychedelic pharmaceutical treatments…